SE0102289D0 - New use of compound - Google Patents

New use of compound

Info

Publication number
SE0102289D0
SE0102289D0 SE0102289A SE0102289A SE0102289D0 SE 0102289 D0 SE0102289 D0 SE 0102289D0 SE 0102289 A SE0102289 A SE 0102289A SE 0102289 A SE0102289 A SE 0102289A SE 0102289 D0 SE0102289 D0 SE 0102289D0
Authority
SE
Sweden
Prior art keywords
disease
treatment
compound
diarrhea
edema
Prior art date
Application number
SE0102289A
Other languages
English (en)
Inventor
Anders Hamberger
Gunnar Stenhagen
Original Assignee
Anders Hamberger
Gunnar Stenhagen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anders Hamberger, Gunnar Stenhagen filed Critical Anders Hamberger
Priority to SE0102289A priority Critical patent/SE0102289D0/sv
Publication of SE0102289D0 publication Critical patent/SE0102289D0/sv
Priority to DE60204321T priority patent/DE60204321D1/de
Priority to PCT/SE2002/001197 priority patent/WO2003002112A1/en
Priority to AT02741579T priority patent/ATE296096T1/de
Priority to EP02741579A priority patent/EP1408944B1/en
Priority to US10/482,211 priority patent/US20040192782A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE0102289A 2001-06-27 2001-06-27 New use of compound SE0102289D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0102289A SE0102289D0 (sv) 2001-06-27 2001-06-27 New use of compound
DE60204321T DE60204321D1 (de) 2001-06-27 2002-06-19 Erucamid-verbindungen zur behandlung und prävention von störungen des sekretorischen systems
PCT/SE2002/001197 WO2003002112A1 (en) 2001-06-27 2002-06-19 Erucamide compounds for the treatment and prevention to disturbances of the secretory system
AT02741579T ATE296096T1 (de) 2001-06-27 2002-06-19 Erucamid-verbindungen zur behandlung und prävention von störungen des sekretorischen systems
EP02741579A EP1408944B1 (en) 2001-06-27 2002-06-19 Erucamide compounds for the treatment and prevention of disturbances of the secretory system
US10/482,211 US20040192782A1 (en) 2001-06-27 2002-06-19 Erucamide compounds for the treatment and prevention to disturbances of the secretory system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102289A SE0102289D0 (sv) 2001-06-27 2001-06-27 New use of compound

Publications (1)

Publication Number Publication Date
SE0102289D0 true SE0102289D0 (sv) 2001-06-27

Family

ID=20284639

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102289A SE0102289D0 (sv) 2001-06-27 2001-06-27 New use of compound

Country Status (6)

Country Link
US (1) US20040192782A1 (sv)
EP (1) EP1408944B1 (sv)
AT (1) ATE296096T1 (sv)
DE (1) DE60204321D1 (sv)
SE (1) SE0102289D0 (sv)
WO (1) WO2003002112A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6631793B2 (en) * 2001-12-13 2003-10-14 Aircraft Braking Systems Corporation Torque tube and conical back plate for aircraft brake systems
WO2017174557A2 (en) * 2016-04-04 2017-10-12 Brains Online Holding B.V. Use of push pull microdialysis in combination with shotgun proteomics for analyzing the proteome in extracellular space of brain

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940730A (en) * 1987-10-29 1990-07-10 Takeda Chemical Industries, Ltd. Angiogenesis enhancer
US5612380A (en) * 1994-09-27 1997-03-18 The Scripps Research Institute Method for sleep induction
US5952392A (en) * 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
CN1213748C (zh) * 1996-09-17 2005-08-10 阿文尼尔药品公司 包括非离子表面活性剂和活性组分的组合物及其应用
WO1999026584A2 (en) * 1997-11-24 1999-06-03 The Scripps Research Institute Inhibitors of gap junction communication
US6858649B1 (en) * 1998-04-30 2005-02-22 The Scripps Research Institute Selective potentiation of serotonin receptor subtypes
US6365198B1 (en) * 2001-01-28 2002-04-02 Gulf Pharmaceutical Industries Pharmaceutical preparation for the treatment of gastrointestinal ulcers and hemorrhoids

Also Published As

Publication number Publication date
EP1408944B1 (en) 2005-05-25
DE60204321D1 (de) 2005-06-30
WO2003002112A1 (en) 2003-01-09
EP1408944A1 (en) 2004-04-21
ATE296096T1 (de) 2005-06-15
US20040192782A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
MA25809A1 (fr) Derives d'arylmethylamine pour usage comme inhibiteurs de tryptase
BRPI0409417A (pt) método para usar um composto, composto, e, composição
MA31894B1 (fr) Composes organiques
MA26718A1 (fr) Derives de quinoleine-2-one a substituant heteroaryle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
HK1087702A1 (en) Arylmethylamine derivatives for use as tryptase inhibitors
EP1566380A4 (en) ISOQUINOLINONE COMPOUNDS AND THEIR USE FOR MEDICINAL PURPOSES
SE9802549D0 (sv) Quinoline derivatives
MXPA05011150A (es) 2-hidroxi-3-diaminoalcanos de benzamida.
MA27454A1 (fr) Remedes ou produits preventifs pour la frequence urinaire ou l'incontinence urinaire, et derives de morphinane presentant un groupe heterocyclique contenant de l'azote
CA2421114A1 (en) 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
MA28212A1 (fr) 2-carbonylamino-6-piperidinaminopyridines substitues et 1-carbonylamino-3-piperidinaminobenzenes substitues utilises en tant qu'agonistes de 5-ht1f
BR0113389A (pt) Compostos que inibem a atividade do fator xa
ATE279192T1 (de) Die verwendung eines benzimidazoles zur herstellung eines medikamentes zur krebsvorbeugung
BR0210392A (pt) Composto, métodos de tratar um paciente que tenha ou de prevenir um paciente de contrair uma doença ou condição e de preparar um composto, e, uso de um composto
DK0570294T3 (da) 2-formylpyridinthiosemicarbazonderivater, deres fremstilling og deres anvendelse som antitumormiddel
IL159241A0 (en) Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
EP1557414A4 (en) ISOQUINOLINE COMPOUNDS AND THEIR MEDICINAL USE
SE0102289D0 (sv) New use of compound
WO2004054565A8 (en) Pregabalin and derivates thereof for the treatment of fibromyalgia and other related disorders
KR950016753A (ko) 벤조[쥐(g)]퀴놀린의 신규의 사용 방법
NZ332687A (en) use of 1-methyl-carbapenem derivatives as anti-helicobacter pylori agents
BR0112338A (pt) Composto, composição farmacêutica, e, uso de um composto
EA200600022A1 (ru) Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций
DE69911373D1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
EA200600271A1 (ru) Применение производных индазола для лечения невропатической боли